MedPath

Use of single dose intranasal fentanyl for the reduction of pain associated with retinopathy of prematurity screening :RCT

Phase 3
Completed
Conditions
Neonates 30-34 weeks postmenstrual age undergoing screening for retinopathy of prematurity.
Registration Number
CTRI/2017/12/011016
Lead Sponsor
Surya Hospital
Brief Summary

Standard pain relief measures used in neonates such as oral sucrose, oral paracetamol, proparacaine eye drops, EBM, non nutritive sucking , swaddling, KMC etc may be inadequate in relieving pain associated with screening  for ROP.

Intranasal fentanyl is a standard analgesic used in children for severe pain.

We hypothesized that administration of fentanyl intranasally in addition to standard pain relief would result in a further 50 % reduction in Pain score (PIPP)in premature neonates undergoing ROP screening . 56 patients would  need to be recruited for a study power of 90% and two tailed alpha of 0.05.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
112
Inclusion Criteria

Neonates 30-34 weeks postmenstrual age undergoing screening for retinopathy of prematurity.

Exclusion Criteria
  • 1.Infant receiving sedation or analgesic medications for any reason.
  • 2.Infants on mechanical ventilation.
  • 3.Any congenital malformations, or neurological dysfunction.
  • 4.Parents refusing consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.PIPP score (Premature infant pain profile) during screening for retinopathy of prematurity1.PIPP score (Premature infant pain profile) during screening for retinopathy of prematurity
Secondary Outcome Measures
NameTimeMethod
1.PIPP score during screening for retinopathy of prematurity2.PIPP score post laser :time point 1,5,10 minutes post procedure

Trial Locations

Locations (1)

Surya Child Care PVT. LTD

🇮🇳

(Suburban), MAHARASHTRA, India

Surya Child Care PVT. LTD
🇮🇳(Suburban), MAHARASHTRA, India
Dr jagdish kathwate
Principal investigator
7666490985
docjagdishkat@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.